- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Barbara Balik: Focus on System Issues, Not the Individual, to Prevent Burnout
The main causes of burnout stem from the system of the practice, not individual behaviors, said Barbara Balik, EdD, MS, RN, co-founder of Aefina Partners and senior faculty at the Institute of Healthcare Improvement.
The main causes of burnout stem from the system of the practice, not individual behaviors, said Barbara Balik, EdD, MS, RN, co-founder of Aefina Partners and senior faculty at the Institute of Healthcare Improvement.
Transcript
Are there some bad practices that organizations looking to address clinician burnout should avoid?
One of the things that I’m seeing right now that does not contribute or help people find joy in work is that sole reliance on individual resiliency. So the belief that if I just helped you develop your resiliency maybe through great practices like mindfulness or wellness activities, then your burnout will go away. That is only part of the answer.
Some people believe that it’s about 80% systems issues and 20% individually. Whether, that’s the right percentage or not, I think it gives us an indication that far more things in the work environment, the care environment, the system in which we all function contributes to burnout far more than the individual. Solely functioning, focusing on the individual when it’s the system, that’s a mistake and I encourage people not to make that mistake. Identify what in the system is getting in the way of a good day.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer
June 2nd 2025Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free survival (PFS) in HER2-positive breast cancer, potentially representing a new standard of care.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Assay Finds Patients Who Will Benefit From Adjuvant Chemotherapy in Early-Stage NSCLC
May 31st 2025Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing and artificial intelligence could offer new tools for assessing risk.
Read More
